{"id":"https://openalex.org/W2206004388","doi":null,"title":"Challenges of adherence management in human immunodeficiency virus pharmacotherapy.","display_name":"Challenges of adherence management in human immunodeficiency virus pharmacotherapy.","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2206004388","mag":"2206004388","pmid":"https://pubmed.ncbi.nlm.nih.gov/14712324"},"language":"en","primary_location":{"id":"pmid:14712324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14712324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000900914","display_name":"Laura Y. Park\u2010Wyllie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I4210089665","display_name":"St Michael\u2019s Hospital","ror":"https://ror.org/008te2062","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210089665"]},{"id":"https://openalex.org/I4405285936","display_name":"MAP Centre for Urban Health Solutions","ror":"https://ror.org/00qkmqj58","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4399598460","https://openalex.org/I4405285936"]}],"countries":["CA","IE"],"is_corresponding":false,"raw_author_name":"Laura Y Park-Wyllie","raw_affiliation_strings":["Inner City Health Research Unit, St Michael's Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inner City Health Research Unit, St Michael's Hospital","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I4210089665","https://openalex.org/I4405285936"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080985934","display_name":"Elizabeth Jane Phillips","orcid":"https://orcid.org/0000-0002-7623-3383","observed_orcids":["https://orcid.org/0000-0002-7623-3383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth J Phillips","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7765,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.77141567,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"4","first_page":"189","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.8252000212669373,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.8252000212669373,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.16590000689029694,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.6129999756813049},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.875},{"id":"https://openalex.org/keywords/pill-burden","display_name":"medication burden","score":0.7179999947547913},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9419999718666077},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8379999995231628},{"id":"https://openalex.org/keywords/reasons-for-non-adherence","display_name":"reasons for non-adherence","score":0.9010000228881836},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8109999895095825},{"id":"https://openalex.org/keywords/barriers-to-adherence","display_name":"barriers to adherence","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8806687593460083},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6916736960411072},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.6883010864257812},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6567806005477905},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.6098282337188721},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5627573728561401},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4746197760105133},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.437005877494812},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.405262291431427},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.26429569721221924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13260415196418762},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11155891418457031}],"mesh":[{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012959","descriptor_name":"Socioeconomic Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:14712324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14712324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique","raw_type":"Journal Article"},{"id":"pmh:oai:alma.61MUN_INST:11135888870007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Challenges-of-adherence-management-in-human/991005542816407891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:16086","doi":null,"is_oa":false,"landing_page_url":"http://researchrepository.murdoch.edu.au/id/eprint/16086/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Park-Wyllie, L.Y. and Phillips, E.J. <http://researchrepository.murdoch.edu.au/view/author/Phillips, Elizabeth.html> (2003) Challenges of adherence management in human immunodeficiency virus pharmacotherapy. Canadian Journal of Clinical Pharmacology, 10 (4). pp. 189-195.","raw_type":"Journal Article"},{"id":"mag:2206004388","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14712324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2324331232","https://openalex.org/W1550035398","https://openalex.org/W2015199696","https://openalex.org/W2071688855","https://openalex.org/W2071683523","https://openalex.org/W71618226","https://openalex.org/W2152397210","https://openalex.org/W2035980098","https://openalex.org/W2048610403","https://openalex.org/W2102391548"],"abstract_inverted_index":{"Medication":[0],"adherence":[1,71,104,119,146],"to":[2,72,80,130,144],"highly":[3],"active":[4,39],"antiretroviral":[5,74,102],"therapy":[6],"(HAART)":[7],"is":[8,77,105],"currently":[9],"a":[10,108],"topic":[11],"of":[12,63,70,114],"major":[13],"importance":[14,113],"in":[15],"human":[16],"immunodeficiency":[17,20],"virus":[18],"(HIV)/acquired":[19],"syndrome":[21],"care.":[22],"HAART":[23,64],"has":[24],"dramatically":[25],"reduced":[26],"morbidity":[27],"and":[28,40,89,120,125,137,141],"mortality":[29],"from":[30],"HIV":[31,36],"infection.":[32],"Many":[33],"people":[34],"with":[35,43,93,107],"now":[37],"live":[38],"productive":[41],"lives,":[42],"the":[44,60,83,98,112,116,123,138],"disease":[45],"itself":[46],"having":[47],"minimal":[48],"impact":[49],"on":[50,110],"their":[51],"lifespan.":[52],"Unlike":[53],"treatment":[54,121],"for":[55,135],"other":[56],"chronic":[57],"diseases,":[58],"achieving":[59],"full":[61],"benefit":[62],"requires":[65],"an":[66],"extremely":[67],"high":[68,84],"level":[69],"potent":[73],"combinations":[75],"that":[76],"often":[78],"difficult":[79],"achieve":[81,131],"given":[82],"pill":[85],"burdens,":[86],"drug":[87],"interactions":[88],"adverse":[90],"events":[91],"associated":[92],"treatment.":[94],"In":[95],"this":[96],"paper,":[97],"present":[99],"knowledge":[100],"regarding":[101],"medication":[103],"summarized":[106],"focus":[109],"understanding":[111],"adherence,":[115,133],"relationship":[117],"between":[118],"response,":[122],"challenges":[124],"barriers":[126],"facing":[127],"patients":[128],"trying":[129],"optimal":[132],"reasons":[134],"nonadherence,":[136],"current":[139],"directions":[140],"issues":[142],"relevant":[143],"future":[145],"research.":[147]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}